Baby Dalisha More, a 3-year-old girl, has been diagnosed with Philadelphia chromosome-positive (Ph+) Acute B-Cell Lymphoblastic Leukemia (ALL), a rare and aggressive form of blood cancer. This type of leukemia is characterized by the presence of the Philadelphia chromosome, which makes the disease more difficult to treat and requires a specific and intensive treatment protocol.

Dalisha has been experiencing symptoms consistent with acute leukemia, including fatigue, fever, easy bruising or bleeding, bone and joint pain, and frequent infections. Her diagnosis was confirmed through a series of blood tests and bone marrow examination.

The recommended treatment for Dalisha's Ph+ Acute B-Cell Lymphoblastic Leukemia involves a comprehensive and intensive approach, which includes:

1. Chemotherapy: A multi-phase regimen of chemotherapy drugs designed to induce remission, eradicate leukemic cells, and prevent relapse.
2. Targeted Therapy: Use of tyrosine kinase inhibitors (TKIs) specifically targeting the Philadelphia chromosome to improve treatment outcomes.
3. Supportive Care: This includes blood transfusions, antibiotics to prevent or treat infections, pain management, and nutritional support to help Dalisha tolerate the aggressive treatment regimen.

The cost of comprehensive treatment for Ph+ Acute B-Cell Lymphoblastic Leukemia, including multiple cycles of chemotherapy, targeted therapy, supportive care, medications, and hospitalization, is substantial. It is estimated that the total cost for Dalisha's treatment at SRCC Children's Hospital will be approximately 1,800,000 INR.

Dalisha's father works as a daily sales person, earning a modest income to support the family. However, the cost of his daughter's medical treatment far exceeds their financial means. The family's financial situation, combined with the urgent need for intensive treatment, makes it impossible for them to afford the necessary medical care for Dalisha.

Given the critical nature of Dalisha's condition and the dire financial circumstances faced by her family, we earnestly request assistance in securing funding or resources to cover the cost of her medical treatment. Every effort will be made to ensure that Baby Dalisha receives the specialized and life-saving care she urgently needs to combat her leukemia.

Your support and assistance during this critical time will make a profound difference in Baby Dalisha's life and her family's well-being. We appeal to your compassion and generosity in helping to alleviate their financial burden and provide them with the hope and reassurance they need during this challenging journey.

Thank you for your attention to this matter. We remain hopeful for a positive response and deeply appreciate any assistance you may be able to provide

All donations made to Saaya Foundation are exempt under section 80G of the Income Tax Act. Registered ID: U85300MH2022NPL383369

Saaya Foundation, a National Registered Charity is raising funds for Baby Dalisha More.

Saaya Foundation works in the areas of Medical Support, Women Empowerment, Child Rights, Social Awareness Programs, Protection from Domestic Violence, Health Initiatives, Personality Development Programs, Education, Natural Calamity Relief and other impact driven programs.